127 related articles for article (PubMed ID: 26994587)
21. Efficacy of a Cap-Dependent Endonuclease Inhibitor and Neuraminidase Inhibitors against H7N9 Highly Pathogenic Avian Influenza Virus Causing Severe Viral Pneumonia in Cynomolgus Macaques.
Suzuki S; Nguyen CT; Ogata-Nakahara A; Shibata A; Osaka H; Ishigaki H; Okamatsu M; Sakoda Y; Kida H; Ogasawara K; Itoh Y
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33257455
[TBL] [Abstract][Full Text] [Related]
22. Emergence of H7N9 Influenza A Virus Resistant to Neuraminidase Inhibitors in Nonhuman Primates.
Itoh Y; Shichinohe S; Nakayama M; Igarashi M; Ishii A; Ishigaki H; Ishida H; Kitagawa N; Sasamura T; Shiohara M; Doi M; Tsuchiya H; Nakamura S; Okamatsu M; Sakoda Y; Kida H; Ogasawara K
Antimicrob Agents Chemother; 2015 Aug; 59(8):4962-73. PubMed ID: 26055368
[TBL] [Abstract][Full Text] [Related]
23. Subcutaneous inoculation of a whole virus particle vaccine prepared from a non-pathogenic virus library induces protective immunity against H7N7 highly pathogenic avian influenza virus in cynomolgus macaques.
Itoh Y; Ozaki H; Ishigaki H; Sakoda Y; Nagata T; Soda K; Isoda N; Miyake T; Ishida H; Okamoto K; Nakayama M; Tsuchiya H; Torii R; Kida H; Ogasawara K
Vaccine; 2010 Jan; 28(3):780-9. PubMed ID: 19857455
[TBL] [Abstract][Full Text] [Related]
24. A Highly Pathogenic Avian H7N9 Influenza Virus Isolated from A Human Is Lethal in Some Ferrets Infected via Respiratory Droplets.
Imai M; Watanabe T; Kiso M; Nakajima N; Yamayoshi S; Iwatsuki-Horimoto K; Hatta M; Yamada S; Ito M; Sakai-Tagawa Y; Shirakura M; Takashita E; Fujisaki S; McBride R; Thompson AJ; Takahashi K; Maemura T; Mitake H; Chiba S; Zhong G; Fan S; Oishi K; Yasuhara A; Takada K; Nakao T; Fukuyama S; Yamashita M; Lopes TJS; Neumann G; Odagiri T; Watanabe S; Shu Y; Paulson JC; Hasegawa H; Kawaoka Y
Cell Host Microbe; 2017 Nov; 22(5):615-626.e8. PubMed ID: 29056430
[TBL] [Abstract][Full Text] [Related]
25. Novel avian-origin human influenza A(H7N9) can be transmitted between ferrets via respiratory droplets.
Xu L; Bao L; Deng W; Dong L; Zhu H; Chen T; Lv Q; Li F; Yuan J; Xiang Z; Gao K; Xu Y; Huang L; Li Y; Liu J; Yao Y; Yu P; Li X; Huang W; Zhao X; Lan Y; Guo J; Yong W; Wei Q; Chen H; Zhang L; Qin C
J Infect Dis; 2014 Feb; 209(4):551-6. PubMed ID: 23990570
[TBL] [Abstract][Full Text] [Related]
26. Quantitative analysis of the yield of avian H7 influenza virus haemagglutinin protein produced in silkworm pupae with the use of the codon-optimized DNA: A possible oral vaccine.
Nerome K; Matsuda S; Maegawa K; Sugita S; Kuroda K; Kawasaki K; Nerome R
Vaccine; 2017 Feb; 35(5):738-746. PubMed ID: 28065477
[TBL] [Abstract][Full Text] [Related]
27. Low pathogenic avian influenza A(H7N9) virus causes high mortality in ferrets upon intratracheal challenge: a model to study intervention strategies.
Kreijtz JH; Kroeze EJ; Stittelaar KJ; de Waal L; van Amerongen G; van Trierum S; van Run P; Bestebroer T; T Kuiken ; Fouchier RA; Rimmelzwaan GF; Osterhaus AD
Vaccine; 2013 Oct; 31(43):4995-9. PubMed ID: 23816392
[TBL] [Abstract][Full Text] [Related]
28. Disease severity is associated with differential gene expression at the early and late phases of infection in nonhuman primates infected with different H5N1 highly pathogenic avian influenza viruses.
Muramoto Y; Shoemaker JE; Le MQ; Itoh Y; Tamura D; Sakai-Tagawa Y; Imai H; Uraki R; Takano R; Kawakami E; Ito M; Okamoto K; Ishigaki H; Mimuro H; Sasakawa C; Matsuoka Y; Noda T; Fukuyama S; Ogasawara K; Kitano H; Kawaoka Y
J Virol; 2014 Aug; 88(16):8981-97. PubMed ID: 24899188
[TBL] [Abstract][Full Text] [Related]
29. Intranasal seasonal influenza vaccine and a TLR-3 agonist, rintatolimod, induced cross-reactive IgA antibody formation against avian H5N1 and H7N9 influenza HA in humans.
Overton ET; Goepfert PA; Cunningham P; Carter WA; Horvath J; Young D; Strayer DR
Vaccine; 2014 Sep; 32(42):5490-5. PubMed ID: 25128802
[TBL] [Abstract][Full Text] [Related]
30. Pandemic Swine-Origin H1N1 Influenza Virus Replicates to Higher Levels and Induces More Fever and Acute Inflammatory Cytokines in Cynomolgus versus Rhesus Monkeys and Can Replicate in Common Marmosets.
Mooij P; Koopman G; Mortier D; van Heteren M; Oostermeijer H; Fagrouch Z; de Laat R; Kobinger G; Li Y; Remarque EJ; Kondova I; Verschoor EJ; Bogers WM
PLoS One; 2015; 10(5):e0126132. PubMed ID: 25946071
[TBL] [Abstract][Full Text] [Related]
31. H5 N-terminal β sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccine.
Khurana S; Coyle EM; Verma S; King LR; Manischewitz J; Crevar CJ; Carter DM; Ross TM; Golding H
Vaccine; 2014 Nov; 32(48):6421-32. PubMed ID: 25284811
[TBL] [Abstract][Full Text] [Related]
32. H7N9: can H7N3 live-attenuated influenza vaccine be used at the early stage of the pandemic?
Rudenko L; Isakova-Sivak I; Rekstin A
Expert Rev Vaccines; 2014 Jan; 13(1):1-4. PubMed ID: 24308582
[TBL] [Abstract][Full Text] [Related]
33. Pathobiological Origins and Evolutionary History of Highly Pathogenic Avian Influenza Viruses.
Lee DH; Criado MF; Swayne DE
Cold Spring Harb Perspect Med; 2021 Feb; 11(2):. PubMed ID: 31964650
[TBL] [Abstract][Full Text] [Related]
34. Newcastle Disease Virus-Vectored H7 and H5 Live Vaccines Protect Chickens from Challenge with H7N9 or H5N1 Avian Influenza Viruses.
Liu Q; Mena I; Ma J; Bawa B; Krammer F; Lyoo YS; Lang Y; Morozov I; Mahardika GN; Ma W; García-Sastre A; Richt JA
J Virol; 2015 Jul; 89(14):7401-8. PubMed ID: 25926639
[TBL] [Abstract][Full Text] [Related]
35. Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses.
Zhang L; Jia N; Li J; Han Y; Cao W; Wang S; Huang Z; Lu S
Hum Vaccin Immunother; 2014; 10(7):1949-58. PubMed ID: 25424804
[TBL] [Abstract][Full Text] [Related]
36. Experimental infection of Cynomolgus Macaques with highly pathogenic H5N1 influenza virus through the aerosol route.
Watanabe T; Iwatsuki-Horimoto K; Kiso M; Nakajima N; Takahashi K; Jose da Silva Lopes T; Ito M; Fukuyama S; Hasegawa H; Kawaoka Y
Sci Rep; 2018 Mar; 8(1):4801. PubMed ID: 29556081
[TBL] [Abstract][Full Text] [Related]
37. Intranasal vaccination with H5, H7 and H9 hemagglutinins co-localized in a virus-like particle protects ferrets from multiple avian influenza viruses.
Tretyakova I; Pearce MB; Florese R; Tumpey TM; Pushko P
Virology; 2013 Jul; 442(1):67-73. PubMed ID: 23618102
[TBL] [Abstract][Full Text] [Related]
38. Protection Against H7 Subtype Influenza Virus Infection in Mice by Passive Transfer of Neutralizing Monoclonal Antibody.
Zhang Z; Liu M; Zheng S
Monoclon Antib Immunodiagn Immunother; 2015 Oct; 34(5):360-5. PubMed ID: 26492625
[TBL] [Abstract][Full Text] [Related]
39. Upconversion luminescence resonance energy transfer (LRET)-based biosensor for rapid and ultrasensitive detection of avian influenza virus H7 subtype.
Ye WW; Tsang MK; Liu X; Yang M; Hao J
Small; 2014 Jun; 10(12):2390-7. PubMed ID: 24599581
[TBL] [Abstract][Full Text] [Related]
40. Widespread Virus Replication in Alveoli Drives Acute Respiratory Distress Syndrome in Aerosolized H5N1 Influenza Infection of Macaques.
Wonderlich ER; Swan ZD; Bissel SJ; Hartman AL; Carney JP; O'Malley KJ; Obadan AO; Santos J; Walker R; Sturgeon TJ; Frye LJ; Maiello P; Scanga CA; Bowling JD; Bouwer AL; Duangkhae PA; Wiley CA; Flynn JL; Wang J; Cole KS; Perez DR; Reed DS; Barratt-Boyes SM
J Immunol; 2017 Feb; 198(4):1616-1626. PubMed ID: 28062701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
